Clinical Trial Update: Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides. [NA]

View source ↗

Summary

This completed clinical trial compared fenofibrate (Tricor), rosiglitazone (Avandia), and a weight-loss intervention to reduce cardiovascular risk factors in pe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia
• Insulin Resistance

Drugs mentioned

• Avandia (rosiglitazone)
• Tricor (fenofibrate)

Snippet

Sponsor: Stanford University | Conditions: Insulin Resistance, Hypertriglyceridemia | NA | Status: COMPLETED | Results posted: 2016-05-05